These include commonly prescribed drugs such as Ozempic or Wegovy (semaglutide), Saxenda (liraglutide), Zepbound (tirzepatide ...

Expiry of Novo Nordisk’s UK patent for Saxenda seen as offering a ‘dry run’ for future generic versions of Ozempic ...

As for why it’s not approved for weight loss in the UK, Dr Kayat added: “It works by helping to regulate your appetite and ...

13 in the journal JAMA Network Open. By comparison, Saxenda (liraglutide) prompted similar weight loss in only 29% of those being treated for obesity and 12% being treated for type 2 diabetes.

India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks ...

The weight-loss drug liraglutide helped obese children ... are the first to demonstrate the effects of liraglutide (Saxenda) on children ages 6 to 11. "The results of this study offer considerable ...

In a much-anticipated release, the Congressional Budget Office (CBO) published projections estimating it would cost Medicare ...

Despite the benefits of such medicines, like Wegovy, Saxenda and Zepbound, many people who could most benefit from them can’t ...

Weight-loss injections have revolutionized obesity treatment in adults, and now, their effectiveness has been proven in children. A new study revealed that the injection "Saxenda" led to significant ...

Liraglutide lowered body mass, slowed weight gain and improved health markers ... in adults and children ages 10 and older and as Saxenda to treat obesity in adults and children ages 12 to 17.